BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Berbers RM, Mohamed Hoesein FAA, Ellerbroek PM, van Montfrans JM, Dalm VASH, van Hagen PM, Paganelli FL, Viveen MC, Rogers MRC, de Jong PA, Uh HW, Willems RJL, Leavis HL. Low IgA Associated With Oropharyngeal Microbiota Changes and Lung Disease in Primary Antibody Deficiency. Front Immunol 2020;11:1245. [PMID: 32636843 DOI: 10.3389/fimmu.2020.01245] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
Number Citing Articles
1 Varricchi G, Poto R, Ianiro G, Punziano A, Marone G, Gasbarrini A, Spadaro G. Gut Microbiome and Common Variable Immunodeficiency: Few Certainties and Many Outstanding Questions. Front Immunol 2021;12:712915. [PMID: 34408753 DOI: 10.3389/fimmu.2021.712915] [Reference Citation Analysis]
2 Xiang L, Meng X. Emerging cellular and molecular interactions between the lung microbiota and lung diseases. Crit Rev Microbiol 2021;:1-34. [PMID: 34693852 DOI: 10.1080/1040841X.2021.1992345] [Reference Citation Analysis]
3 Demirdag YY, Gupta S. Update on Infections in Primary Antibody Deficiencies. Front Immunol 2021;12:634181. [PMID: 33643318 DOI: 10.3389/fimmu.2021.634181] [Reference Citation Analysis]
4 Bosák J, Lexa M, Fiedorová K, Gadara DC, Micenková L, Spacil Z, Litzman J, Freiberger T, Šmajs D. Patients With Common Variable Immunodeficiency (CVID) Show Higher Gut Bacterial Diversity and Levels of Low-Abundance Genes Than the Healthy Housemates. Front Immunol 2021;12:671239. [PMID: 34054845 DOI: 10.3389/fimmu.2021.671239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 van de Ven AAJM, Alfaro TM, Robinson A, Baumann U, Bergeron A, Burns SO, Condliffe AM, Fevang B, Gennery AR, Haerynck F, Jacob J, Jolles S, Malphettes M, Meignin V, Milota T, van Montfrans J, Prasse A, Quinti I, Renzoni E, Stolz D, Warnatz K, Hurst JR. Managing Granulomatous-Lymphocytic Interstitial Lung Disease in Common Variable Immunodeficiency Disorders: e-GLILDnet International Clinicians Survey. Front Immunol 2020;11:606333. [PMID: 33324422 DOI: 10.3389/fimmu.2020.606333] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Lamers OAC, Smits BM, Leavis HL, de Bree GJ, Cunningham-Rundles C, Dalm VASH, Ho HE, Hurst JR, IJspeert H, Prevaes SMPJ, Robinson A, van Stigt AC, Terheggen-Lagro S, van de Ven AAJM, Warnatz K, van de Wijgert JHHM, van Montfrans J. Treatment Strategies for GLILD in Common Variable Immunodeficiency: A Systematic Review. Front Immunol 2021;12:606099. [PMID: 33936030 DOI: 10.3389/fimmu.2021.606099] [Reference Citation Analysis]
7 Huus KE, Petersen C, Finlay BB. Diversity and dynamism of IgA-microbiota interactions. Nat Rev Immunol 2021;21:514-25. [PMID: 33568782 DOI: 10.1038/s41577-021-00506-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 11] [Article Influence: 6.0] [Reference Citation Analysis]
8 Zhao Y, Zhang P, Ding J, Li Y, Su Y, Cao X, Chen C, Zhu Y, Jiang G, Shen L. An exploratory analysis of the lung microbiome and immune status in lung transplant recipients. J Infect 2022:S0163-4453(22)00343-7. [PMID: 35659546 DOI: 10.1016/j.jinf.2022.05.031] [Reference Citation Analysis]